Navigation Links
CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
Date:12/1/2009

VIENNA, Va., Dec. 1 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM), a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®. This CRO is considered to be one of the world's top CRO's for running global oncology studies.

The impending Phase III trial is expected to enroll up to 800 patients with advanced primary head and neck cancer in multiple countries around the world. It will evaluate Multikine's ability to increase the overall survival of treated patients when used in conjunction with the current standard of care treatment.

"We are very pleased to have retained the services of a well respected and internationally recognized CRO which specializes in conducting late-stage oncology trials to guide our pivotal Phase III trial for Multikine," said Geert Kersten, Chief Executive Officer of CEL-SCI. "After carefully evaluating many competing organizations, we have chosen this CRO based on their extensive experience in managing global clinical trials of medicines ultimately approved for the treatment of cancer."

In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck. CEL-SCI recently took delivery of its new state of the
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
6. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI Corporation Announces 2007 Financial Results
9. CEL-SCI Corporation Reports First Quarter Financial Results
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... ANGELES , April 21, 2015  Legal-Bay ... that Pradaxa,s maker, Boehringer Ingelheim Pharmaceuticals, is seeking ... DVT and PE. According to PBR, Boehringer submitted ... FDA in hopes that Pradaxa will be approved ... and pulmonary embolism (PE) for patients who have ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... - Dr. Gregory Taylor , Canada,s ... today after spending a week in West Africa ... and needs on the ground as global efforts continue to reach ... and prevention efforts in Sierra Leone and ... see first-hand the work being done and hear from those on ...
Breaking Medicine Technology:Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3U.S. Census Bureau Daily Feature for April 21 2Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5
(Date:4/21/2015)... April 21, 2015 The American Society ... cosmetic dermatologist Fredric S. Brandt, M.D., by setting up ... an ASDS member since 1982, died earlier this month ... are designed to provide opportunities for ASDS members, industry ... cosmetic dermatology that Dr. Brandt held so dear. , ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 A team of ... Newbury, MA, is participating in the Race Across America to ... to Empower” includes racers from all disciplines of cycling; road ... climbers. The team of 8 has a mission to race ... the 2015 RAAM for the ultimate challenge in endurance, teamwork ...
(Date:4/21/2015)... Washington, DC (PRWEB) April 21, 2015 ... to announce the launch of Medicare-Medicaid Dual Eligibles ... that focuses on care provided to the more ... U.S. who account for more than $300 billion ... in-house researchers – the same team that also ...
(Date:4/21/2015)... Washington, DC (PRWEB) April 21, 2015 ... poll released today by Clements Worldwide indicates that international ... among would-be expatriates. , The survey by Clements, a ... living and working outside of their country of citizenship, ... the availability of appropriate health care insurance overseas ...
(Date:4/21/2015)... 2015 Bulk food-grade transportation services ... of 5, indicating generally favorable purchasing conditions for buyers. ... to entry and the fact that most bulk food ... distances,” says IBISWorld research analyst Hayden Shipp. “As such, ... serving local and regional markets.” Suppliers include Ruan Transportation ...
Breaking Medicine News(10 mins):Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4Health News:Domestic Violence & Homicide Awareness, Prevention, and Education, To Be The Focus For Massachusetts Racing Team In Race Across America 2Health News:Domestic Violence & Homicide Awareness, Prevention, and Education, To Be The Focus For Massachusetts Racing Team In Race Across America 3Health News:Domestic Violence & Homicide Awareness, Prevention, and Education, To Be The Focus For Massachusetts Racing Team In Race Across America 4Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 3Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3
... are, the more accurate a picture you get when you ... ability to simultaneously measure as many as 100 or more ... disease such as cancer, that capability would provide a much ... , A Stanford University School of Medicine team led by ...
... Industries, Inc. ( www.sanitecindustries.com ),the global patent holder ... Disinfection System(TM), has successfully emerged from its Chapter ... for the Central District of California ruled yesterday ... Industries should be confirmed thus clearing the way ...
... has successfully implemented TransportConnect(TM) at Intuitive Surgical ... DGN Technologies, Inc. announced today that ... Surgical, located in Sunnyvale, California, USA. ... and selected TransportConnect(TM) to address the specific ...
... got milk? Milk Mustache,Mobile Drink Well. Live Well. Tour ... and its array of benefits. The Tour,cruised through Atlanta ... only live well but to drink well with nature,s ... little face of wellness!...Luciano Liberona was very excited to ...
... could reduce related blindness by almost 35%, study suggests, ... rate of age-related macular degeneration is on the increase, ... of the disease by about 35 percent, new estimates ... Centers for Disease Control and Prevention, researchers report that ...
... of Transplantation Joins James Redford on May 30 ... to Raise Transplant Awareness BOSTON, April ... the American Society of Transplantation (AST) will host Share the ... benefit organ donation awareness and transplant research . Share the ...
Cached Medicine News:Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 2Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 3Health News:Sanitec Industries Emerges From Chapter 11 2Health News:DGN Technologies TransportConnect(TM) Successfully Implemented at Intuitive Surgical 2Health News:DGN Technologies TransportConnect(TM) Successfully Implemented at Intuitive Surgical 3Health News:The Hispanic Got Milk? Campaign Recently Visited Atlanta Promoting the Drink Well. Live Well. Tour! 2Health News:Nearly 18 Million Will Have Macular Degeneration by 2050 2Health News:Nearly 18 Million Will Have Macular Degeneration by 2050 3Health News:Country Star Phil Vassar to Perform at Transplantation Fundraiser 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: